M&T Bank Corp Ionis Pharmaceuticals Inc Transaction History

M&T Bank Corp

$231 Billion
Q4 2024

A detailed history of M&T Bank Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, M&T Bank Corp holds 6,096 shares of IONS stock, worth $183,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,096

Previous 8,896 31.47%

Holding current value

$183,916

Previous $356,000 40.17%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$33.73 - $40.36 $94,443 - $113,008	-2,800 Reduced 31.47%	6,096 $213,000
Q3 2024 Nov 15, 2024	BUY	$40.06 - $51.86 $2,804 - $3,630	70 Added 0.79%	8,896 $356,000
Q2 2024 Jul 31, 2024	BUY	$36.45 - $47.7 $108,548 - $142,050	2,978 Added 50.92%	8,826 $420,000
Q1 2024 May 07, 2024	BUY	$42.03 - $53.55 $27,739 - $35,343	660 Added 12.72%	5,848 $253,000
Q4 2023 Feb 06, 2024	BUY	$43.39 - $51.63 $16,314 - $19,412	376 Added 7.81%	5,188 $262,000
Q3 2023 Nov 02, 2023	SELL	$38.5 - $47.13 $13,398 - $16,401	-348 Reduced 6.74%	4,812 $218,000
Q2 2023 Aug 09, 2023	BUY	$34.73 - $43.33 $179,206 - $223,582	5,160 New	5,160 $211,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $12,167 - $16,203	-333 Reduced 6.05%	5,168 $229,000
Q2 2022 Aug 05, 2022	BUY	$31.71 - $43.0 $174,436 - $236,543	5,501 New	5,501 $204,000
Q1 2021 May 06, 2021	SELL	$42.51 - $63.78 $539,877 - $810,006	-12,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $2,083 - $2,772	46 Added 0.36%	12,700 $717,000
Q3 2020 Nov 06, 2020	SELL	$47.45 - $62.95 $14,377 - $19,073	-303 Reduced 2.34%	12,654 $600,000
Q2 2020 Jul 29, 2020	BUY	$46.85 - $61.05 $9,276 - $12,087	198 Added 1.55%	12,957 $765,000
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $95,097 - $144,932	-2,286 Reduced 15.19%	12,759 $603,000
Q4 2019 Feb 07, 2020	BUY	$53.85 - $65.27 $53,365 - $64,682	991 Added 7.05%	15,045 $909,000
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $11,871 - $14,502	201 Added 1.45%	14,054 $843,000
Q2 2019 Aug 12, 2019	BUY	$62.09 - $86.14 $113,190 - $157,033	1,823 Added 15.15%	13,853 $891,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $19,527 - $29,951	369 Added 3.16%	12,030 $976,000
Q4 2018 Feb 01, 2019	BUY	$43.37 - $59.54 $1,691 - $2,322	39 Added 0.34%	11,661 $630,000
Q3 2018 Nov 09, 2018	SELL	$42.88 - $53.7 $50,040 - $62,667	-1,167 Reduced 9.13%	11,622 $599,000
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $22,494 - $28,138	555 Added 4.54%	12,789 $532,000
Q1 2018 May 04, 2018	BUY	$44.08 - $55.05 $7,581 - $9,468	172 Added 1.43%	12,234 $540,000
Q4 2017 Feb 06, 2018	SELL	$50.3 - $64.39 $14,637 - $18,737	-291 Reduced 2.36%	12,062 $606,000
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $10,159 - $13,284	223 Added 1.84%	12,353 $628,000
Q2 2017 Aug 11, 2017	BUY	N/A	12,130	12,130 $617,000

Others Institutions Holding IONS

# of Institutions

411

Shares Held

132M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.28B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account